A citation-based method for searching scientific literature

R Manchanda, M Burnell, A Abdelraheim, M Johnson, A Sharma, E Benjamin, C Brunell, E Saridogan, S Gessler, D Oram, L Side, A N Rosenthal, I Jacobs, U Menon. BJOG 2012
Times Cited: 38

List of co-cited articles
370 articles co-cited >1

Times Cited
  Times     Co-cited

Time to prophylactic surgery in BRCA1/2 carriers depends on psychological and other characteristics.
Claire Julian-Reynier, Anne-Déborah Bouhnik, Emanuelle Mouret-Fourme, Marion Gauthier-Villars, Pascaline Berthet, Christine Lasset, Jean-Pierre Fricker, Olivier Caron, Paul Gesta, Elisabeth Luporsi,[...]. Genet Med 2010

Cancer statistics, 2012.
Rebecca Siegel, Deepa Naishadham, Ahmedin Jemal. CA Cancer J Clin 2012

A prospective study of quality of life among women undergoing risk-reducing salpingo-oophorectomy versus gynecologic screening for ovarian cancer.
Carolyn Y Fang, Carol Cherry, Karthik Devarajan, Tianyu Li, John Malick, Mary B Daly. Gynecol Oncol 2009

Prophylactic bilateral salpingo-oophorectomy compared with surveillance in women with BRCA mutations.
Kathleen M Schmeler, Charlotte C Sun, Diane C Bodurka, Kristin G White, Pamela T Soliman, Anne R Uyei, Julie L Erlichman, Banu K Arun, Molly S Daniels, Susan A Rimes,[...]. Obstet Gynecol 2006

Breast cancer risk after bilateral prophylactic oophorectomy in BRCA1 mutation carriers.
T R Rebbeck, A M Levin, A Eisen, C Snyder, P Watson, L Cannon-Albright, C Isaacs, O Olopade, J E Garber, A K Godwin,[...]. J Natl Cancer Inst 1999

Psychosocial impact of breast/ovarian (BRCA1/2) cancer-predictive genetic testing in a UK multi-centre clinical cohort.
M Watson, C Foster, R Eeles, D Eccles, S Ashley, R Davidson, J Mackay, P J Morrison, P Hopwood, D G R Evans. Br J Cancer 2004

Screening for familial ovarian cancer: poor survival of BRCA1/2 related cancers.
D G Evans, K N Gaarenstroom, D Stirling, A Shenton, L Maehle, A Dørum, M Steel, F Lalloo, J Apold, M E Porteous,[...]. J Med Genet 2009

Outcome of surveillance and prophylactic salpingo-oophorectomy in asymptomatic women at high risk for ovarian cancer.
Paul A M Meeuwissen, Caroline Seynaeve, Cecile T M Brekelmans, Hanne J Meijers-Heijboer, Jan G M Klijn, Curt W Burger. Gynecol Oncol 2005

Determination of quality of life-related utilities for health states relevant to ovarian cancer diagnosis and treatment.
Laura J Havrilesky, Gloria Broadwater, Debra M Davis, Kimberly C Nolte, J Cory Barnett, Evan R Myers, Shalini Kulasingam. Gynecol Oncol 2009

The association between early menopause and risk of ischaemic heart disease: influence of Hormone Therapy.
E Løkkegaard, Z Jovanovic, B L Heitmann, N Keiding, B Ottesen, A T Pedersen. Maturitas 2006

Differences in natural history between breast cancers in BRCA1 and BRCA2 mutation carriers and effects of MRI screening-MRISC, MARIBS, and Canadian studies combined.
Eveline A M Heijnsdijk, Ellen Warner, Fiona J Gilbert, Madeleine M A Tilanus-Linthorst, Gareth Evans, Petrina A Causer, Rosalind A Eeles, Reinie Kaas, Gerrit Draisma, Elizabeth A Ramsay,[...]. Cancer Epidemiol Biomarkers Prev 2012

The clinical effectiveness and cost-effectiveness of different surveillance mammography regimens after the treatment for primary breast cancer: systematic reviews registry database analyses and economic evaluation.
C Robertson, S K Arcot Ragupathy, C Boachie, J M Dixon, C Fraser, R Hernández, S Heys, W Jack, G R Kerr, G Lawrence,[...]. Health Technol Assess 2011

Screening with magnetic resonance imaging and mammography of a UK population at high familial risk of breast cancer: a prospective multicentre cohort study (MARIBS).
M O Leach, C R M Boggis, A K Dixon, D F Easton, R A Eeles, D G R Evans, F J Gilbert, I Griebsch, R J C Hoff, P Kessar,[...]. Lancet 2005

Prognosis after ipsilateral breast tumor recurrence and locoregional recurrences in patients treated by breast-conserving therapy in five National Surgical Adjuvant Breast and Bowel Project protocols of node-negative breast cancer.
Stewart J Anderson, Irene Wapnir, James J Dignam, Bernard Fisher, Eleftherios P Mamounas, Jong-Hyeon Jeong, Charles E Geyer, D Lawrence Wickerham, Joseph P Costantino, Norman Wolmark. J Clin Oncol 2009

Next-generation DNA sequencing.
Jay Shendure, Hanlee Ji. Nat Biotechnol 2008

Prognosis after ipsilateral breast tumor recurrence and locoregional recurrences in five National Surgical Adjuvant Breast and Bowel Project node-positive adjuvant breast cancer trials.
Irene L Wapnir, Stewart J Anderson, Eleftherios P Mamounas, Charles E Geyer, Jong-Hyeon Jeong, Elizabeth Tan-Chiu, Bernard Fisher, Norman Wolmark. J Clin Oncol 2006

Prophylactic salpingectomy and delayed oophorectomy as an alternative for BRCA mutation carriers.
Janice S Kwon, Anna Tinker, Gary Pansegrau, Jessica McAlpine, Melissa Housty, Mary McCullum, C Blake Gilks. Obstet Gynecol 2013

Non-cancer endpoints in BRCA1/2 carriers after risk-reducing salpingo-oophorectomy.
J V Cohen, L Chiel, L Boghossian, M Jones, J E Stopfer, J Powers, T R Rebbeck, K L Nathanson, S M Domchek. Fam Cancer 2012

Increased risk of parkinsonism in women who underwent oophorectomy before menopause.
W A Rocca, J H Bower, D M Maraganore, J E Ahlskog, B R Grossardt, M de Andrade, L J Melton. Neurology 2008

Risk-reducing salpingectomy with delayed oophorectomy in BRCA1/2 mutation carriers: patients' and professionals' perspectives.
Marieke Arts-de Jong, Marline G Harmsen, Nicoline Hoogerbrugge, Leon F Massuger, Rosella P Hermens, Joanne A de Hullu. Gynecol Oncol 2015

BRCA1 and BRCA2 mutations account for a large proportion of ovarian carcinoma cases.
Tuya Pal, Jenny Permuth-Wey, Judith A Betts, Jeffrey P Krischer, James Fiorica, Hector Arango, James LaPolla, Mitchell Hoffman, Martin A Martino, Katie Wakeley,[...]. Cancer 2005

Genetic heterogeneity and penetrance analysis of the BRCA1 and BRCA2 genes in breast cancer families. The Breast Cancer Linkage Consortium.
D Ford, D F Easton, M Stratton, S Narod, D Goldgar, P Devilee, D T Bishop, B Weber, G Lenoir, J Chang-Claude,[...]. Am J Hum Genet 1998

Breast and ovarian cancer risks to carriers of the BRCA1 5382insC and 185delAG and BRCA2 6174delT mutations: a combined analysis of 22 population based studies.
A C Antoniou, P D P Pharoah, S Narod, H A Risch, J E Eyfjord, J L Hopper, H Olsson, O Johannsson, A Borg, B Pasini,[...]. J Med Genet 2005

Risk Algorithm Using Serial Biomarker Measurements Doubles the Number of Screen-Detected Cancers Compared With a Single-Threshold Rule in the United Kingdom Collaborative Trial of Ovarian Cancer Screening.
Usha Menon, Andy Ryan, Jatinderpal Kalsi, Aleksandra Gentry-Maharaj, Anne Dawnay, Mariam Habib, Sophia Apostolidou, Naveena Singh, Elizabeth Benjamin, Matthew Burnell,[...]. J Clin Oncol 2015

Opportunistic salpingectomy: uptake, risks, and complications of a regional initiative for ovarian cancer prevention.
Jessica N McAlpine, Gillian E Hanley, Michelle M M Woo, Alicia A Tone, Nirit Rozenberg, Kenneth D Swenerton, C Blake Gilks, Sarah J Finlayson, David G Huntsman, Dianne M Miller. Am J Obstet Gynecol 2014

Early salpingectomy (TUbectomy) with delayed oophorectomy to improve quality of life as alternative for risk-reducing salpingo-oophorectomy in BRCA1/2 mutation carriers (TUBA study): a prospective non-randomised multicentre study.
Marline G Harmsen, Marieke Arts-de Jong, Nicoline Hoogerbrugge, Angela H E M Maas, Judith B Prins, Johan Bulten, Steven Teerenstra, Eddy M M Adang, Jurgen M J Piek, Helena C van Doorn,[...]. BMC Cancer 2015

Breast and ovarian cancer risk management in a French cohort of 158 women carrying a BRCA1 or BRCA2 germline mutation: patient choices and outcome.
Pascale This, Anne de la Rochefordière, Alexia Savignoni, Marie Christine Falcou, Anne Tardivon, Fabienne Thibault, Séverine Alran, Virgine Fourchotte, Alfred Fitoussi, Benoit Couturaud,[...]. Fam Cancer 2012

Sexual activity and functioning after risk-reducing salpingo-oophorectomy: Impact of hormone replacement therapy.
Nora Johansen, Astrid H Liavaag, Tom G Tanbo, Alv A Dahl, Are H Pripp, Trond M Michelsen. Gynecol Oncol 2016

Early Detection of Ovarian Cancer using the Risk of Ovarian Cancer Algorithm with Frequent CA125 Testing in Women at Increased Familial Risk - Combined Results from Two Screening Trials.
Steven J Skates, Mark H Greene, Saundra S Buys, Phuong L Mai, Powel Brown, Marion Piedmonte, Gustavo Rodriguez, John O Schorge, Mark Sherman, Mary B Daly,[...]. Clin Cancer Res 2017

Population screening for BRCA1/BRCA2 founder mutations in Ashkenazi Jews: proactive recruitment compared with self-referral.
Sari Lieberman, Ariela Tomer, Avi Ben-Chetrit, Oded Olsha, Shalom Strano, Rachel Beeri, Sivan Koka, Hila Fridman, Karen Djemal, Itzhak Glick,[...]. Genet Med 2017

Genetic screening for gynecological cancer: where are we heading?
Ranjit Manchanda, Ian Jacobs. Future Oncol 2016

RE: Breast Cancer Risk After Salpingo-Oophorectomy in Healthy BRCA1/2 Mutation Carriers: Revisiting the Evidence for Risk Reduction.
Xinglei Chai, Susan Domchek, Noah Kauff, Timothy Rebbeck, Jinbo Chen. J Natl Cancer Inst 2015

Results of annual screening in phase I of the United Kingdom familial ovarian cancer screening study highlight the need for strict adherence to screening schedule.
Adam N Rosenthal, Lindsay Fraser, Ranjit Manchanda, Philip Badman, Susan Philpott, Jessica Mozersky, Richard Hadwin, Fay H Cafferty, Elizabeth Benjamin, Naveena Singh,[...]. J Clin Oncol 2013

Genomics of Ovarian Cancer Progression Reveals Diverse Metastatic Trajectories Including Intraepithelial Metastasis to the Fallopian Tube.
Mark A Eckert, Shawn Pan, Kyle M Hernandez, Rachel M Loth, Jorge Andrade, Samuel L Volchenboum, Pieter Faber, Anthony Montag, Ricardo Lastra, Marcus E Peter,[...]. Cancer Discov 2016

Persistence of fimbrial tissue on the ovarian surface after salpingectomy.
Carmen Gan, Rashna Chenoy, Dhivya Chandrasekaran, Elly Brockbank, Antony Hollingworth, Sotiris Vimplis, Alexandra C Lawrence, Arjun R Jeyarajah, David Oram, Nandita Deo,[...]. Am J Obstet Gynecol 2017

Evidence of Stage Shift in Women Diagnosed With Ovarian Cancer During Phase II of the United Kingdom Familial Ovarian Cancer Screening Study.
Adam N Rosenthal, Lindsay S M Fraser, Susan Philpott, Ranjit Manchanda, Matthew Burnell, Philip Badman, Richard Hadwin, Ivana Rizzuto, Elizabeth Benjamin, Naveena Singh,[...]. J Clin Oncol 2017

The BOADICEA model of genetic susceptibility to breast and ovarian cancers: updates and extensions.
A C Antoniou, A P Cunningham, J Peto, D G Evans, F Lalloo, S A Narod, H A Risch, J E Eyfjord, J L Hopper, M C Southey,[...]. Br J Cancer 2008

A study of over 35,000 women with breast cancer tested with a 25-gene panel of hereditary cancer genes.
Saundra S Buys, John F Sandbach, Amanda Gammon, Gayle Patel, John Kidd, Krystal L Brown, Lavania Sharma, Jennifer Saam, Johnathan Lancaster, Mary B Daly. Cancer 2017

Commentary on changing the risk threshold for surgical prevention of ovarian cancer.
R Manchanda, R Legood, A C Antoniou, L Pearce, U Menon. BJOG 2018

Cost-effectiveness of population based BRCA testing with varying Ashkenazi Jewish ancestry.
Ranjit Manchanda, Shreeya Patel, Antonis C Antoniou, Ephrat Levy-Lahad, Clare Turnbull, D Gareth Evans, John L Hopper, Robert J Macinnis, Usha Menon, Ian Jacobs,[...]. Am J Obstet Gynecol 2017

Satisfaction with ovarian carcinoma risk-reduction strategies among women at high risk for breast and ovarian carcinoma.
Shannon N Westin, Charlotte C Sun, Karen H Lu, Kathleen M Schmeler, Pamela T Soliman, Robin A Lacour, Kristin G Johnson, Molly S Daniels, Banu K Arun, Susan K Peterson,[...]. Cancer 2011

Variation in rates of uptake of preventive options by Canadian women carrying the BRCA1 or BRCA2 genetic mutation.
Kelly A Metcalfe, Parviz Ghadirian, Barry Rosen, William Foulkes, Charmaine Kim-Sing, Andrea Eisen, Peter Ainsworth, Doug Horsman, Christine Maugard, Diane Provencher,[...]. Open Med 2007

Very high uptake of risk-reducing salpingo-oophorectomy in BRCA1/2 mutation carriers: A single-center experience.
M G Harmsen, M Arts-de Jong, K Horstik, P Manders, L F A G Massuger, R P M G Hermens, N Hoogerbrugge, G H Woldringh, J A de Hullu. Gynecol Oncol 2016

Co-cited is the co-citation frequency, indicating how many articles cite the article together with the query article. Similarity is the co-citation as percentage of the times cited of the query article or the article in the search results, whichever is the lowest. These numbers are calculated for the last 100 citations when articles are cited more than 100 times.